We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF

513 hedge funds and large institutions have $2.37B invested in ARK Genomic Revolution ETF in 2021 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 206 increasing their positions, 155 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 206 | Existing positions reduced: 155

16% more capital inflows, than outflows

Capital inflows: $289M | Capital outflows: $249M

1% more funds holding

Funds holding: 507 → 513 (+6)

3% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 60

0.87% more ownership

Funds ownership: 23.65% → 24.52% (+0.87%)

12% less funds holding in top 10

Funds holding in top 10: 17 → 15 (-2)

44% less call options, than puts

Call options by funds: $456M | Put options by funds: $812M

Holders
513
Holders Change
+6
Holders Change %
+1.18%
% of All Funds
8.89%
Holding in Top 10
15
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-11.76%
% of All Funds
0.26%
New
62
Increased
206
Reduced
155
Closed
60
Calls
$456​M
Puts
$812​M
Net Calls
-⁠$356​M
Net Calls Change
+$252​M

ARKG Hedge Fund Activity: Q2 2021 in Review

513 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2021, worth a combined $2.37B — up 6.1% from $2.24B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new ARKG positions and 60 closed out — a net gain of 2 holders — while 206 added to existing stakes and 155 trimmed.

The largest buyer was Bank of America, adding an estimated $49.1M. The largest seller was OMERS Administration Corp, exiting entirely with an estimated $34.7M sold.

  • 513 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2021, up from 507 in Q1 2021.
  • Funds reported $2.37B of ARK Genomic Revolution ETF stock for Q2 2021, up 6.1% quarter-over-quarter.
  • 62 funds opened new ARK Genomic Revolution ETF positions in Q2 2021 and 60 closed out, a net change of +2 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q2 2021 was Bank of America, an estimated $49.1M added.
  • The largest ARK Genomic Revolution ETF seller in Q2 2021 was OMERS Administration Corp, an estimated $34.7M sold.

Based on aggregated 13F filings for Q2 2021.